|Year : 2020 | Volume
| Issue : 3 | Page : 79-83
Clinical evaluation of mineral trioxide aggregate in the surgical management of degree I and degree II furcation defects
Rajneesh Parimoo1, Baljeet Singh2, Rajesh Gupta3
1 Department of Periodontology and Oral Implantology, Desh Bhagat Dental College and Hospital, Fatehgarh, Punjab, India
2 Department of Periodontology and Oral Implantology, Bhojia Dental College and Hospital, Baddi, Himachal Pradesh, India
3 Department of Periodontology and Oral Implantology, Swami Devi Dyal Hospital and Dental College, Barwala, Haryana, India
|Date of Submission||18-Jun-2020|
|Date of Decision||09-Jul-2020|
|Date of Acceptance||01-Sep-2020|
|Date of Web Publication||17-Oct-2020|
H. No 131/2 Lane 3, Govind Nagar, Talab Tillo, Jammu - 180 002, Jammu and Kashmir
Source of Support: None, Conflict of Interest: None
Background: Mineral trioxide aggregate (MTA) is known as a strong bioactive material which induces hard tissue formation. It does not get contaminated with tissue fluids or blood and has low cytotoxicity with good antibacterial effects. Objectives: This study aims to evaluate the clinical effectiveness of MTA in the surgical management of Degree I and Degree II furcation defects. Methods: Individuals were 15 patients exhibiting clinical and radiographic evidence of Degree I and Degree II furcation defects. The pocket probing depth, plaque index, gingival index, relative vertical clinical attachment level, relative horizontal clinical attachment level, and gingival recession level of subjects were recorded at baseline, 3 months, and 6 months. Data were analyzed at a significance level of P < 0.05 using paired t-test. Results: The purpose of this study was to maintain furcation involved teeth with the use of MTA. Regeneration of periodontal attachment apparatus by MTA was not the goal of the treatment technique used in this study. However, MTA application results improvement in the recorded clinical parameters.
Conclusion: MTA is effective in obliterating the Degree I and Degree II furcation defects. There are no signs and symptoms of any adverse effect to this treatment.
Keywords: Furcation defects, mineral trioxide aggregate, obliterate, periodontitis
|How to cite this article:|
Parimoo R, Singh B, Gupta R. Clinical evaluation of mineral trioxide aggregate in the surgical management of degree I and degree II furcation defects. Sci Dent J 2020;4:79-83
|How to cite this URL:|
Parimoo R, Singh B, Gupta R. Clinical evaluation of mineral trioxide aggregate in the surgical management of degree I and degree II furcation defects. Sci Dent J [serial online] 2020 [cited 2021 Jan 24];4:79-83. Available from: https://www.scidentj.com/text.asp?2020/4/3/79/298170
| Background|| |
Furcation involvement relates to bone destruction and attachment loss in the interradicular space that results mainly from plaque-associated periodontal disease. This condition considerably raises the chances of tooth loss. The maxillary first molars are usually more affected than mandibular first molars. Once the lesion has developed, the variance of bacterial insult between the root surfaces and the periodontal soft tissues is responsible for a reduced healing response. A significant periodontal attachment and osseous structure loss occurs, resulting in a guarded long-term prognosis. The ideal end result of the furcation therapy is its closure.
Once the osseous defect develops, the surgical modalities for the management includes: Open flap debridement alone in the furcation, open flap debridement in conjuction with bone grafts, and bone grafts with or without guided tissue regeneration. The common observation in the last few years is that the outcomes have improved due to understanding of the disease process and wound healing. Recently, materials such as amalgam, glass ionomer, and polymeric reinforced zinc oxide eugenol have proven to obliterate furcations and improve hygiene by removing the anatomic niches within the furcation, where bacteria go and accumulate.
All the strategies are directed at regenerating the lost periodontal structures. Recently, an innovative material, mineral trioxide aggregate (MTA) has been tried in the management of furcation defects. MTA was first introduced by Torabinejad et al. at Lomalinda University and was reported in the dental literature in 1993. MTA is a powder comprising of fine hydrophilic particles which gets set in the presence of moisture. It is basically a combination of a refined Portland cement and bismuth oxide with inclusion of dicalcium silicate, tricalcium silicate, tricalcium aluminate, and tetra calcium aluminoferrite and is also known to contain minor quantity of other mineral oxides such as SiO2, CaO2, MgO, K2 SO4, and Na2 SO4, which affects its physical and chemical properties. Similar to calcium hydroxide which possesses antimicrobial properties too, MTA, after setting has a pH of 12.5.
MTA is known as a strong bioactive material which induces hard tissue formation, and is biocompatible. It does not get contaminated with tissue fluids or blood and has low cytotoxicity with good antibacterial effects. In addition, MTA enhances cement oblast attachment, growth, and production of mineralized matrix. Apart from this, it results in differentiation of osteoblasts and cement oblasts in human periodontal ligament cells, which results in expression of calcium sensing receptors and bone morphogenetic protein-2 receptors that are potentially involved in osteogenesis.
Considering these novel properties and abilities of the MTA in promoting regeneration, present study was planned and carried out with an aim to clinically evaluate the effectiveness of MTA in the surgical management of Degree I and Degree II furcation defects.
| Materials and Methods|| |
This study was approved by the institutional ethical committee and was carried out on 15 patients in the age group of 20–65 years, from either sex, in the Department of Periodontology and Oral Implantology, Bhojia Dental College and Hospital, Baddi (Himachal Pradesh). All the patients received verbal information regarding the study protocol and a written informed consent was obtained from each patient for participation in the study.
Patients exhibiting clinical and radiographic evidence of Degree I (Horizontal loss of periodontal tissue support <3 mm) and Degree II (Horizontal loss of periodontal tissue support exceeding 3 mm but not encompassing the total width of the defect) furcation defects in the mandibular 1st and 2nd molars (buccal and lingual defects) were selected from amongst the patients visiting the department. The study was carried out on 18 patients with 18 defects, in the age group of 20–65 years. Out of these, 15 patients (13 males and 2 females) with 15 defects completed the follow-up of 6 months.
- Systemically healthy controls
- Patients in the age group of 20–65 years
- Patients exhibiting clinical and radiographic evidence of Degree I and Degree II furcation defects
- Asymptomatic teeth, without any pulpal or periapical pathology
- Teeth with no mobility
- Patients willing to sign the consent form.
- Patients with complicated medical history
- Patients with metabolic bone diseases, for example, osteoporosis and rheumatoid arthritis
- Patients undergoing radiotherapy or chemotherapy
- Pregnant and lactating female patients
- Untreated, nonvital teeth.
After performing the oral prophylaxis and occlusal adjustments (where necessary), customized acrylic stent was fabricated for each patient on the study casts. Acrylic stent was trimmed to the height of contours of the teeth and apical border of the stent acted as the fixed reference point. To ensure the reproducibility in the placement of the periodontal probes, for vertical and horizontal probing of the furcation defects, a vertical groove (mid buccal or lingual) was prepared in the stent. Clinical parameters (full mouth/site specific) were recorded as the baseline data: plaque index (PI), gingival index (GI), pocket probing depth (PPD), relative vertical clinical attachment level (RVCAL), relative horizontal clinical attachment level (RHCAL), and gingival margin level/gingival recession (GR).
Intraoral periapical radiographs were taken to confirm the evidence of furcation involvement and include the teeth in study. Radiographs were again taken at baseline, 3 months, and 6 months, postoperative to assess the status of MTA in the furcation defects and evidence of bone fill, if any.
Before proceeding with the surgical procedure, detailed history and all the clinical parameters were recorded as the baseline data. After proper isolation of the surgical field, the site to be operated upon was adequately anesthetized using local anaesthesia. Intracrevicular incision was performed extending two teeth anterior and one tooth posterior to the tooth/teeth under consideration and a full thickness flap was raised [Figure 1]. Defect debridement and root planing was carried out carefully with hand and ultrasonic instruments to remove subgingival plaque, calculus, and inflammatory granulation tissue. After debridement, the MTA was placed at the defect site (degree I and degree II furcations) [Figure 2]. The material was compacted into the defect [Figure 3]. The flap was sutured back as far as possible at a coronal position in an attempt to cover the furcation defect [Figure 4].
|Figure 2: Tooth No. 46-mineral trioxide aggregate being placed in the furcation defect|
Click here to view
|Figure 3: Mineral trioxide aggregate being compacted in the furcation defect|
Click here to view
|Figure 4: Tooth No. 46-sutures given after placement of mineral trioxide aggregate|
Click here to view
Postoperative care and follow-up intervals
All the patients were prescribed necessary antibiotics, analgesic anti-inflammatory drugs, and 0.2% chlorhexidine mouth wash. Routine postsurgical instructions were given to the patients and the patients were asked to report after 1 week for suture removal and at any time in case of an adverse event. Seven days following the surgery, sutures were removed and the surgical site was irrigated with saline. Patients were recalled at 3 months and 6 months. At each visit oral hygiene instructions were reinforced, and the same clinical parameters (i.e., PPD, PI, GI, RVCAL, RHCAL, and GR) were recorded and standardized intraoral periapical radiographs were taken.
After the completion of the study, statistical analysis was carried out. The results of the study were subjected to statistical analysis by applying paired t- test IBM SPSS statistical analysis software was used.
| Results|| |
The present study was carried out with the aim of evaluating efficacy of MTA in obliterating the Degree I and Degree II furcation defects.
Plaque index, gingival index-full mouth
Mean scores for PI at first visit, baseline, 3 months and 6 months, postoperative were 1.21 ± 0.72, 0.20 ± 0.23, 1.07 ± 0.80, and 1 ± 0.88, respectively. The difference from baseline to 3 months was highly significant (P < 0.001) and from baseline to 6 months was also highly significant (P < 0.001). Mean scores for GI at first visit, baseline, 3 months, and 6 months, postoperatively were 1.39 ± 0.69, 1.12 ± 0.58, 1.07 ± 0.74, and 1.07 ± 0.80, respectively. The difference from baseline to 3 months was statistically nonsignificant (P > 0.05) and from baseline to 6 months was also statistically nonsignificant (P > 0.05) [Figure 5].
|Figure 5: Comparison of plaque and gingival indices at different time intervals|
Click here to view
Pocket probing depth
In comparison with baseline, there was statistically significant (P < 0.05) reduction in PPD at 3 and 6 months following surgery on mesiobuccal, buccal, and lingual surfaces. However, there was no statistically significant reduction (P > 0.05) in PPD at 3 and 6 months on the distobuccal surface [Table 1].
|Table 1: Comparison of mean scores±standard deviation of pocket probing depth at different time intervals|
Click here to view
Relative vertical clinical attachment level
When compared to the baseline values, there was statistically significant (P < 0.05) reduction on the mesiobuccal, buccal, and lingual surfaces at 3 months and 6 months, postoperatively [Table 2]. There was no statistically significant (P > 0.05) reduction observed on distobuccal surface after 3 months.
|Table 2: Comparison of mean scores±standard deviation of relative vertical clinical attachment level at different time intervals|
Click here to view
Relative horizontal clinical attachment level
The mean RHCAL values at baseline on the buccal and lingual surfaces were 10.07 ± 1.75 and 9.60 ± 2.26, respectively. There was statistically significant (P < 0.05) reduction in the RHCAL on the buccal and lingual surfaces at 3 and 6 months' postoperatively [Table 3].
|Table 3: Comparison of mean scores±standard deviation of relative horizontal clinical attachment level at different time intervals|
Click here to view
Gingival margin level/gingival recession
The mean GR on mesiobuccal, buccal, distobuccal, and lingual tooth surfaces was recorded at baseline, 3 months, and 6 months. When compared to the baseline value 5.73 ± 1.33, there was reduction only on lingual surface at 3 months 5.67 ± 1.39 and 6 months 5.67 ± 1.39.
| Discussion|| |
The main goal of periodontal therapy is to provide patients with a dentition that functions in health and comfort for the remainder of their lives. Molars are the tooth type demonstrating the highest rate of periodontal destruction in untreated disease and suffer the highest frequency of loss for periodontal reasons. Furcation defects have presented a major challenge to therapists because of their unique anatomical characteristics and their variable response to treatment.
As shown by many longitudinal studies, resective, and tissue attachment techniques have slowed the progression of disease but have been unable to stop attachment loss. Consequently, furcation involvement has been synonymous with more advanced forms of periodontitis and a more guarded prognosis for long-term tooth retention.
In the past, restorative materials such as polymeric-reinforced zinc oxide eugenol intermediate restorative, amalgam, glass ionomer, and resin ionomer restorative materials have been used to obliterate furcation. The goal was to improve plaque control by eliminating the anatomic niches within the furcation where bacteria can accumulate.
van Swol et al. compared amalgam, zinc oxyphosphate cement, and glass ionomer in the treatment of surgically created furcation in nonhuman primates. The authors reported the greatest biocompatibility with glass ionomer through radiographic and histological evaluation. Scherer and Dragoo utilized modified resin ionomer restorations subgingivally and gave histological evidence of epithelial and connective tissue adherence to the resin ionomer restorative materials.
Ghanbari et al. evaluated the efficacy of MTA and calcium enriched mixture cement in class II furcation defects in human mandibular molars. The evaluation of soft-tissue outcomes at 3 months' postoperation showed significant improvements in vertical clinical attachment level and horizontal clinical attachment level in both groups compared to baseline. The evaluation of hard tissue outcomes at the 6 months re-entry showed significant improvements in vertical and horizontal bone fills in both the groups in comparison to baseline. The improvements in vertical bone fill and horizontal bone gain in the MTA group were 3.5 mm (P < 0.001) and 3.76 mm (P = 0.002), respectively. Singhal reported a case involving the use of glass ionomer cement (GIC) as an occlusive barrier in the management of Class III furcation defect involving mandibular first molar, patient was asymptomatic on 1-year recall visit and was able to maintain the oral hygiene easily.
In an animal study conducted by Miranda et al. reported significant reduction in PPD, where he used GIC in Degree II furcation defects. Results of the study conducted by Patil et al. stated that use of GIC in Degree III furcation defects proved to reduce probing depth and gain in clinical attachment level. Reddy et al. presented two cases with Class III furcation defects involving all three furcation in the right and left maxillary first molars. Their results showed that the gingival margin was maintained without much recession.
Since, no re-entry procedures permitting direct observation of the bone fill and histological studies were performed; it is not possible to make any comment regarding the regeneration of periodontal attachment apparatus.
Based on the results of the present study, it appears that MTA is an efficacious material in managing the Degree I and Degree II furcation defects. Therefore, MTA can be considered as an alternative to other more expensive regenerative treatment modalities for furcation defects. Further long term, randomized, controlled clinical trials are needed to know the effects of such treatment modalities.
| Conclusion|| |
The use of MTA has proven to be a viable method in obliterating the furcation defects. The excellent handling properties and excellent tissue response to the material are definite benefits. The purpose of selecting this mode of therapy was simply to obliterate and to prevent further attachment loss in mandibular molars with Degree I and Degree II furcation defects.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Cattabriga M, Pedrazzoli V, Wilson TG Jr. The conservative approach in the treatment of furcation lesions. Periodontol 2000 2000;22:133-53.
Meng HX. Periodontic-endodontic lesions. Ann Periodontol 1999;4:84-90.
Anderegg CR, Metzler DG. Retention of multi-rooted teeth with Class III furcation lesions utilizing resins. Report of 17 cases. J Periodontol 2000;71:1043-7.
Ghanbari HO, Taheri M, Abolfazli S, Asgary S, Gharechahi M. Efficacy of MTA and CEM cement with collagen membranes for treatment of Class II furcation defects. J Dent (Tehran) 2014;11:343-54.
Lee SJ, Monsef M, Torabinejad M. Sealing ability of a mineral trioxide aggregate for repair of lateral root perforations. J Endod 1993;19:541-4.
Naik RM, Pudakalkatti PS, Hattarki SA. Can MTA be: Miracle trioxide aggregate? J Indian Soc Periodontol 2014;18:5-8.
] [Full text]
Torabinejad M, Parirokh M. Mineral trioxide aggregate: A comprehensive literature review-Part II: Leakage and biocompatibility investigations. J Endod 2010;36:190-202.
Maeda H, Nakano T, Tomokiyo A, Fujii S, Wada N, Monnouchi S,et al
. Mineral trioxide aggregate induces bone morphogenetic protein-2 expression and calcification in human periodontal ligament cells. J Endod 2010;36:647-52.
Hamp SE, Nyman S, Lindhe J. Periodontal treatment of multi-rooted teeth. J Clin Periodontol 1975;2:126-35.
Girish MS. Root resection: An interdisciplinary approach in the management of Grade-III furcation defects. Int J Dent Case Reports 2013;3:48-51.
McClain PK, Schallhorn RG. Focus on furcation defects-guided tissue regeneration in combination with bone grafting. Periodontol 2000 2000;22:190-212.
Patil T, Waghmare P, Mali A, Agrawal P, Patil KP. Novel approach of retention of maxillary molars with grade III furcation involvement with the use of glass ionomer cement. J Int Clin Dent Res Organ 2015;7:64-68. [Full text]
van Swol RL, Eslami A, Sadeghi EM, Ellinger RF. New treatment for furcation defects involving strategic molars. Int J Periodontics Restorative Dent 1989;9:185-95.
Scherer W, Dragoo MR. New clinical applications for resin ionomer. Pract Periodontics Aesthetic Dent 1995;7:1-4.
Singhal R. Glass ionomer cement as an occlusive barrier in class III furcation defect. Indian J Dent Res 2011;22:583-6.
] [Full text]
Miranda LA, Gomes SC, Soares IJ, Oppermann RV. A resin-modified glass ionomer cement barrier for treating degree II furcation defects: A pilot study in dogs. Acta Odontol Scand 2006;64:37-41.
Reddy KP, Nayak DG, Uppoor AS. Retention of maxillary molars with Class III furcation involvement utilizing glass-ionomer: Two case reports. J Contemp Dent Pract 2005;6:160-7.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2], [Table 3]